Cite
HARVARD Citation
Morio, K. et al. (2017). Real‐world efficacy and safety of daclatasvir and asunaprevir therapy for hepatitis C virus‐infected cirrhosis patients. Journal of gastroenterology and hepatology. 32 (3), pp. 645-650. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Morio, K. et al. (2017). Real‐world efficacy and safety of daclatasvir and asunaprevir therapy for hepatitis C virus‐infected cirrhosis patients. Journal of gastroenterology and hepatology. 32 (3), pp. 645-650. [Online].